Actual Medicinal Product (AMP) -
Comirnaty COVID-19 mRNA Vaccine 30micrograms/0.3ml dose concentrate for dispersion for injection multidose vials (Pfizer Ltd)
Name Details
Current Name
Comirnaty COVID-19 mRNA Vaccine 30micrograms/0.3ml dose concentrate for dispersion for injection multidose vials
|
Start Date
08-09-2021
|
End Date
|
Previous Name
COVID-19 mRNA Vaccine Pfizer-BioNTech BNT162b2 30micrograms/0.3ml dose concentrate for dispersion for injection multidose vials
|
Start Date
01-09-2021
|
End Date
07-09-2021
|
|
Abbreviated Name
Comirnaty COVID-19 mRNA Vaccine 0.3ml inj multidose vials
|
Start Date
30-11-2021
|
|
Courageous 30microg/0.3ml dose concentrate for inj multidose |
Previous Start Date
22-10-2020
|
Previous End Date
24-11-2020
|
Summary
- Licensed Route
- Intramuscular
- Availability Restrictions
- Not available
- Licensing Authority
- Medicines - MHRA/EMA
- EMA Indicator
- EMA Monitoring
Codes
BNF |
Previous BNF
14040000
|
Start Date
22-10-2020
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
39115611000001103 |
22-10-2020 |
|
Actual Medicinal Product Pack (AMPP) Information